CD180 and mantle cell lymphoma: Using flow cytometry, it was shown that CD180 was weakly expressed by malignant cells in chronic lymphocytic leukemia (CLL), mantle cell lymphoma and lymphoplasmacytic lymphoma, compared with control  B cells (Miguet et al. 2013; Mayeur-Rousse et al. 2016).